PembrolizumabLoperamideprophylaxisChemoendocrinetherapyAromataseinhibitorsPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)ExemestaneVenlafaxineTDM-1(Ado-trastuzumabemtansine)Radiationtherapy10yearsTaxanesTNBCCapecitabineOlaparibTC (docetaxel /cyclophosphamide)Intermediate(11-25)AbemaciclibAnthracyclines1yearPertuzumabEverymonthTamoxifen2yearsLVEFmonitoringPembrolizumabLoperamideprophylaxisChemoendocrinetherapyAromataseinhibitorsPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)ExemestaneVenlafaxineTDM-1(Ado-trastuzumabemtansine)Radiationtherapy10yearsTaxanesTNBCCapecitabineOlaparibTC (docetaxel /cyclophosphamide)Intermediate(11-25)AbemaciclibAnthracyclines1yearPertuzumabEverymonthTamoxifen2yearsLVEFmonitoring

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Pembrolizumab
  2. Loperamide prophylaxis
  3. Chemoendocrine therapy
  4. Aromatase inhibitors
  5. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  6. Exemestane
  7. Venlafaxine
  8. TDM-1 (Ado-trastuzumab emtansine)
  9. Radiation therapy
  10. 10 years
  11. Taxanes
  12. TNBC
  13. Capecitabine
  14. Olaparib
  15. TC (docetaxel / cyclophosphamide)
  16. Intermediate (11-25)
  17. Abemaciclib
  18. Anthracyclines
  19. 1 year
  20. Pertuzumab
  21. Every month
  22. Tamoxifen
  23. 2 years
  24. LVEF monitoring